<DOC>
	<DOCNO>NCT01971086</DOCNO>
	<brief_summary>Multi-centre , open-label , prospective , uncontrolled , single-arm , non-interventional study ( NIS ) objective collect evaluate data concern treatment Rhinospray Plus everyday curative routine treatment acute rhinitis</brief_summary>
	<brief_title>Treatment With Rhinospray Plus Patients With Acute Rhinitis Everyday Curative Routine Hungary</brief_title>
	<detailed_description>Study Design : open , observational , single-arm , uncontrolled</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Tramazoline</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients ( case 618 year old whose legal representative ) sign Informed Consent 2 . Male female ambulatory outpatient see participate physician office routine care 3 . Patients clinical diagnosis Rhinitis acuta 4 . Patient cognitive functional ability answer symptom specific question 5 . Patients express willingness participate observational study 6 . Patients age 6 7 . Rhinospray Plus naive patient ( patient use Rhinospray Plus ) Exclusion criterion : 1 . Uncooperative patient base physician judgement 2 . Patients condition make application Rhinospray plus contraindicate 3 . Patients currently enrol clinical trial require change medication respiratory problem 4 . Withdraw Informed Consent 5 . Pregnancy breastfeed state Summary Product Characteristic ( SmPC ) 6 . Patients clinical diagnosis allergic rhinitis</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>